Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling. Ding L, Chen X, Zhang W, Dai X, et al. J Clin Invest 2023;133:e154754.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ding L, Chen X, Zhang W, Dai X, et al. Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling. J Clin Invest 2023;133:e154754.
PMID: 36594471